Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Stroke; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency IS-IMA-1745. An 86-years-old male received bnt162b2 (COMIRNATY), via an unspecified route of administration on 20Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included folic acid (FOLSYRA EVOLAN 5 mg), apixaban (ELIQUIS 5 mg), umeclidinium bromide (INCRUSE ELLIPTA 55 mcg for inhalation), allopurinol (ALLONOL 100 mg), mirabegron (BETMIGA 25 mg), cefuroxime (FURIX [CEFUROXIME] 20 mg), metoprolol succinate (BLOXAZOC 50 mg) and FINOL 5mg. The patient experienced stroke and was hospitalized on 24Jan2021. The patient died on 26Jan2021 because of the stroke. The event was serious due to hospitalization and death. The patient underwent lab tests and procedures which included CT scan on 24Jan2021: The conclusion from the scan was: Large parenchyma hemorrhage in the basal ganglia on the left with breakthrough hemorrhage in the cerebral cortex - blood is present in all four cerebral chambers. High volume effect in the form of displacement of midline structures by 13 mm and a narrowed suprasellar cistern. Imminent uncal herniation and incipient hydrocephalus. The event outcome was fatal. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. Batch/Lot numbers can not be obtained.; Reported Cause(s) of Death: Stroke
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166